Katarina Preisler, PA
Physician Assistant · Grand Rapids, MINPI 1821859141
Payments from drug & device makers
Across 9 payments — averaging $102.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$129
- IBSA Pharma Inc.$125
- Aimmune Therapeutics, Inc.$125
- Sumitomo Pharma America, Inc.$122
- Lundbeck LLC$104
- Lilly USA, LLC$98
- plus $218 from 3 others
What the payments were for
- Speaking & faculty fees$12213%
- Food & beverage$79987%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 1 | $129 |
| IBSA Pharma Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Sumitomo Pharma America, Inc. | 1 | $122 |
| Lundbeck LLC | 1 | $104 |
| Lilly USA, LLC | 1 | $98 |
| Neurelis, Inc. | 1 | $90 |
| Acadia Pharmaceuticals Inc | 1 | $83 |
| Teva Pharmaceuticals USA, Inc. | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$921 in reported general payments places this provider in the 70th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $5,800 |
| JardianceEmpagliflozin | 17 | $4,860 |
| EliquisApixaban | 17 | $4,833 |
| PaceroneAmiodarone Hcl | 17 | $1,238 |
| Gabapentin | 104 | $395 |
| Atorvastatin Calcium | 88 | $338 |
| Metolazone | 22 | $296 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $294 |
| Levothyroxine Sodium | 50 | $250 |
| Omeprazole | 35 | $179 |
| Tamsulosin Hcl | 36 | $174 |
| Pantoprazole Sodium | 38 | $140 |
| Finasteride | 29 | $113 |
| Metoprolol Succinate | 20 | $112 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $107 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Melissa JosephGrand Rapids$82K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.